An exploration of the role of trust and rapport in enhancing vaccine uptake among Anishinaabe in rural northern Ontario.

Publication date: Dec 05, 2024

This article examines the complicated terrain of immunization acceptance and access among Indigenous peoples in northern Ontario by drawing on conversations held prior to 2019 that explored knowledge about Haemophilus influenzae type a (Hia) infection specifically and attitudes toward vaccines more broadly. In the decade preceding COVID-19, Hia emerged as a leading cause of morbidity and mortality in Indigenous communities in northern Canada. Before developing new vaccines, it is imperative to hold conversations with the communities most affected and to learn more about Indigenous peoples’ perceptions of and knowledge about vaccines, both generally and Hia specifically. We conducted focus groups and one-on-one conversations with Anishinaabe Peoples in northwestern Ontario. Our findings illustrate that decisions to vaccinate are informed by a host of social, institutional, and ideological factors and historical and contemporary relationships with government institutions and health practitioners. In particular, Indigenous community members perceived their relationships with social and health services and education institutions as coercive. Thus, public health approaches cannot continue to operate in ways that prioritize interventions for Indigenous peoples and communities so that they “do the right thing. ” More emphasis is needed on health service and social service provider knowledge, skills, attitudes and practices-redirecting the onus onto those within the health care system. Solutions must respect Indigenous nationhood and the right of self-determination. Finally, we suggest the term vaccine hesitancy may not entirely capture the breadth of experiences that many Indigenous Peoples and communities have and continue to have within the health care system in Canada.

Open Access PDF

Concepts Keywords
Canada Adult
Decade COVID-19
Host Female
Rural Focus Groups
Vaccine Haemophilus Infections
Humans
Male
Middle Aged
Ontario
Rural Population
Trust
Vaccination

Semantics

Type Source Name
disease IDO role
disease MESH infection
disease MESH COVID-19
disease MESH morbidity
disease IDO host
disease MESH Infectious Diseases
pathway REACTOME Reproduction
disease MESH measles
pathway KEGG Measles
disease MESH pertussis
pathway KEGG Pertussis
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH violence
disease MESH malnutrition
disease MESH Influenza
drug DRUGBANK Polyethylene glycol
disease MESH meningitis
disease MESH septicemia
disease MESH septic arthritis
disease MESH pneumonia
drug DRUGBANK Spinosad
disease IDO history
drug DRUGBANK Albendazole
disease MESH privacy
drug DRUGBANK Coenzyme M
disease IDO production
drug DRUGBANK Ibuprofen
drug DRUGBANK Methylergometrine
disease IDO process
drug DRUGBANK Methionine
drug DRUGBANK Etoperidone
drug DRUGBANK Trestolone
disease IDO country
disease MESH job demands
disease IDO intervention
disease MESH vaccine preventable diseases
drug DRUGBANK Modafinil
drug DRUGBANK Ethionamide
disease MESH Haemophilus influenzae infection
drug DRUGBANK Adenosine 5′-phosphosulfate
disease MESH death
disease MESH tuberculosis
pathway KEGG Tuberculosis
drug DRUGBANK BCG vaccine

Original Article

(Visited 1 times, 1 visits today)